QALSody – What do you think of the FDA passing a new treatment for SOD1 ALS?
Did you know that on April 25th, the FDA approved Tofersen, now called QALSody for SOD1 ALS after a 4-month delay?
What do you think about treatments targeting specific genetic mutations linked to ALS? Do you think that this technology will be helpful for other pALS and other rare diseases?
Sorry, there were no replies found.
Log in to reply.